ArsenalBio (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- October 17, 2019
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $85,000,000
Company Info
- Founding Year
- 2019
- Company Description
- ArsenalBio is a programmable cell therapy company that offers CAR T-cell therapies for solid tumors.
- Market
- Cancer Immunotherapy
- Location
- South San Francisco, California, USA
- Coinvestors
- Euclidean Capital, Kleiner Perkins Caufield and Byers, Osage Venture Partners, Parker Institute for Cancer Immunotherapy, UCSF Foundation Investment Company, Westlake Village BioPartners